<!DOCTYPE html>
<html lang="en" dir="ltr">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Hair Loss Hub | CarePedia Information Center</title>
<link rel="preconnect" href="https://fonts.googleapis.com">
<link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
<link href="https://fonts.googleapis.com/css2?family=Rubik:wght@300;400;500;600;700;800;900&display=swap" rel="stylesheet">
<link rel="alternate" hreflang="he" href="https://carepedia.org/hair-loss" />
<link rel="alternate" hreflang="en" href="https://carepedia.org/en/hair-loss" />

<style>
* { margin: 0; padding: 0; box-sizing: border-box; }

:root {
  --primary: #0f4c75;
  --primary-light: #3282b8;
  --accent: #00b894;
  --accent-light: #55efc4;
  --warm: #fdcb6e;
  --warm-dark: #e17055;
  --bg: #f0f4f8;
  --card: #ffffff;
  --text: #2c3e50;
  --text-light: #5d6d7e;
  --shadow: 0 4px 20px rgba(0,0,0,0.08);
  --shadow-hover: 0 12px 40px rgba(0,0,0,0.18);
  --radius: 16px;
  --transition: all 0.3s cubic-bezier(.4,0,.2,1);
  /* Aliases for Iconify icons */
  --forest: #0f4c75;
  --forest-mid: #3282b8;
  --forest-light: rgba(50,130,184,0.12);
  --amber: #fdcb6e;
  --amber-light: rgba(253,203,110,0.12);
  --border: #dde4eb;
}

body {
  font-family: 'Rubik', 'Segoe UI', Tahoma, Arial, sans-serif;
  background: var(--bg);
  color: var(--text);
  line-height: 1.8;
  overflow-x: hidden;
  position: relative;
}

body::before {
  content: '';
  position: fixed;
  top: 0; left: 0; width: 100vw; height: 100vh;
  background:
    radial-gradient(ellipse at 10% 20%, rgba(15,76,117,0.07) 0%, transparent 50%),
    radial-gradient(ellipse at 90% 80%, rgba(0,184,148,0.07) 0%, transparent 50%),
    radial-gradient(ellipse at 50% 50%, rgba(253,203,110,0.05) 0%, transparent 60%);
  pointer-events: none;
  z-index: 0;
}

.scroll-progress {
  position: fixed;
  top: 0; right: 0;
  width: 100%; height: 4px;
  z-index: 2000;
  background: transparent;
}
.scroll-progress .bar {
  height: 100%; width: 0%;
  background: linear-gradient(90deg, var(--accent), var(--primary-light), var(--warm));
  border-radius: 0 0 0 4px;
  transition: width 0.1s linear;
}

.sidebar {
  position: fixed;
  top: 0; left: 0;
  width: 280px; height: 100vh;
  background: rgba(15,76,117,0.85);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border-right: 1px solid rgba(255,255,255,0.1);
  z-index: 1000;
  padding: 30px 20px;
  overflow-y: auto;
  transition: transform 0.4s cubic-bezier(.4,0,.2,1);
}
.sidebar .logo {
  text-align: center;
  margin-bottom: 30px;
  padding-bottom: 20px;
  border-bottom: 1px solid rgba(255,255,255,0.15);
}
.sidebar .logo .icon { font-size: 48px; }
.sidebar .logo h2 { color: #fff; font-size: 18px; margin-top: 8px; font-weight: 600; }
.sidebar nav a {
  display: flex; align-items: center; gap: 12px;
  padding: 14px 18px; color: rgba(255,255,255,0.8);
  text-decoration: none; border-radius: 12px;
  margin-bottom: 4px; font-size: 15px; transition: var(--transition);
}
.sidebar nav a:hover, .sidebar nav a.active {
  background: rgba(255,255,255,0.15); color: #fff; transform: translateX(4px);
}
.sidebar nav a .nav-icon { font-size: 22px; min-width: 30px; text-align: center; }

.menu-toggle {
  display: none;
  position: fixed;
  top: 20px; left: 20px;
  z-index: 1100;
  background: var(--primary); color: #fff;
  border: none; border-radius: 12px;
  width: 50px; height: 50px; font-size: 24px;
  cursor: pointer; box-shadow: var(--shadow); transition: var(--transition);
}
.menu-toggle:hover { transform: scale(1.05); }
.menu-toggle.open { border-radius: 50%; background: var(--warm-dark); }

.main {
  margin-left: 280px;
  min-height: 100vh;
  position: relative;
  z-index: 1;
}

.hero {
  background: linear-gradient(135deg, var(--primary) 0%, #3282b8 40%, var(--accent) 100%);
  padding: 80px 60px;
  color: #fff;
  position: relative;
  overflow: hidden;
}
.hero::before {
  content: '';
  position: absolute;
  top: -50%; left: -50%;
  width: 200%; height: 200%;
  background: radial-gradient(circle, rgba(255,255,255,0.05) 0%, transparent 60%);
  animation: float 20s linear infinite;
}
@keyframes float { 0% { transform: rotate(0deg); } 100% { transform: rotate(360deg); } }
.hero-content { position: relative; z-index: 1; max-width: 900px; }
.hero h1 { font-size: 52px; font-weight: 800; margin-bottom: 10px; line-height: 1.3; }
.hero .greeting { font-size: 22px; opacity: 0.95; margin-bottom: 30px; line-height: 1.7; }
.hero .subtitle { font-size: 18px; opacity: 0.8; max-width: 700px; }

.fade-in { opacity: 0; transform: translateY(30px); transition: opacity 0.7s ease, transform 0.7s ease; }
.fade-in.visible { opacity: 1; transform: translateY(0); }

.section { padding: 60px; max-width: 1100px; margin: 0 auto; }
.section-header {
  display: flex; align-items: center; gap: 16px;
  margin-bottom: 40px; padding-bottom: 20px;
  border-bottom: 3px solid var(--primary-light);
}
.section-header .sec-icon { font-size: 42px; }
.section-header h2 { font-size: 36px; color: var(--primary); }
.section-header p { color: var(--text-light); font-size: 16px; margin-top: 4px; }

.cards-grid {
  display: grid;
  grid-template-columns: repeat(auto-fill, minmax(300px, 1fr));
  gap: 24px; margin-bottom: 40px;
}
.card {
  background: var(--card); border-radius: var(--radius); padding: 30px;
  box-shadow: var(--shadow); transition: var(--transition);
  border-top: 4px solid var(--primary-light);
  position: relative; overflow: hidden;
}
.card:hover { transform: translateY(-6px) scale(1.01); box-shadow: var(--shadow-hover); }
.card .card-icon { font-size: 40px; margin-bottom: 16px; }
.card h3 { font-size: 20px; color: var(--primary); margin-bottom: 12px; }
.card p { color: var(--text-light); font-size: 15px; line-height: 1.8; }
.card.green { border-top-color: var(--accent); }
.card.orange { border-top-color: var(--warm); }
.card.blue { border-top-color: var(--primary-light); }

.cat-grid {
  display: grid;
  grid-template-columns: repeat(auto-fill, minmax(240px, 1fr));
  gap: 20px; margin-top: 40px;
}
.cat-card {
  background: var(--card); border-radius: var(--radius); padding: 30px 24px;
  text-align: center; cursor: pointer; transition: var(--transition);
  box-shadow: var(--shadow); text-decoration: none; color: var(--text);
}
.cat-card:hover { transform: translateY(-6px) scale(1.02); box-shadow: var(--shadow-hover); }
.cat-card .cat-icon { font-size: 48px; margin-bottom: 14px; }
.cat-card h3 { font-size: 18px; color: var(--primary); margin-bottom: 8px; }
.cat-card p { font-size: 13px; color: var(--text-light); }

.accordion { margin-bottom: 16px; }
.accordion-header {
  background: var(--card); padding: 20px 24px; border-radius: var(--radius);
  cursor: pointer; display: flex; justify-content: space-between; align-items: center;
  box-shadow: var(--shadow); transition: var(--transition);
  font-size: 17px; font-weight: 600; color: var(--primary);
}
.accordion-header:hover { background: #eef4fb; }
.accordion-header .arrow { transition: transform 0.3s ease; font-size: 20px; }
.accordion-header.open .arrow { transform: rotate(180deg); }
.accordion-body {
  max-height: 0; overflow: clip; transition: max-height 0.4s ease;
  background: var(--card); border-radius: 0 0 var(--radius) var(--radius); margin-top: -8px;
}
.accordion-body .inner { padding: 20px 24px 24px; color: var(--text-light); line-height: 2; }

.tabs { display: flex; gap: 8px; margin-bottom: 24px; flex-wrap: wrap; }
.tab-btn {
  padding: 12px 24px; background: var(--card);
  border: 2px solid #dde4eb; border-radius: 30px;
  cursor: pointer; font-size: 15px; font-family: inherit;
  color: var(--text-light); transition: var(--transition);
}
.tab-btn:hover { border-color: var(--primary-light); color: var(--primary); }
.tab-btn.active { background: var(--primary); color: #fff; border-color: var(--primary); }
.tab-content { display: none; animation: fadeIn 0.4s ease; }
.tab-content.active { display: block; }
@keyframes fadeIn { from { opacity: 0; transform: translateY(10px); } to { opacity: 1; transform: translateY(0); } }

.info-box {
  background: linear-gradient(135deg, #eaf4fb 0%, #e8f8f0 100%);
  border-radius: var(--radius); padding: 24px 28px; margin: 24px 0;
  border-left: 5px solid var(--primary-light);
}
.info-box.warning { background: linear-gradient(135deg, #fef9e7 0%, #fdebd0 100%); border-left-color: var(--warm); }
.info-box.success { background: linear-gradient(135deg, #e8f8f0 0%, #d5f5e3 100%); border-left-color: var(--accent); }
.info-box h4 { color: var(--primary); margin-bottom: 8px; font-size: 17px; }
.info-box p { color: var(--text-light); font-size: 15px; }

.link-btn {
  display: inline-flex; align-items: center; gap: 8px;
  padding: 12px 24px; background: var(--primary);
  color: #fff; text-decoration: none; border-radius: 30px;
  font-size: 15px; transition: var(--transition); margin: 6px;
}
.link-btn:hover { background: var(--primary-light); transform: translateY(-2px); }
.link-btn.green { background: var(--accent); }
.link-btn.green:hover { background: var(--accent-light); color: var(--text); }
.link-btn.orange { background: var(--warm-dark); }
.link-btn.orange:hover { background: var(--warm); color: var(--text); }

.styled-table {
  width: 100%; border-collapse: collapse; margin: 20px 0;
  background: var(--card); border-radius: var(--radius);
  overflow: hidden; box-shadow: var(--shadow);
}
.styled-table thead { background: var(--primary); color: #fff; }
.styled-table th { padding: 16px 20px; text-align: left; font-weight: 600; }
.styled-table td { padding: 14px 20px; border-bottom: 1px solid #eee; }
.styled-table tbody tr:hover { background: #f7fafc; }

.timeline { position: relative; padding-left: 40px; margin: 30px 0; }
.timeline::before {
  content: '';
  position: absolute; left: 12px; top: 0; bottom: 0;
  width: 3px;
  background: linear-gradient(to bottom, var(--primary-light), var(--accent));
  border-radius: 3px;
}
.timeline-item {
  position: relative; margin-bottom: 30px; padding: 24px;
  background: var(--card); border-radius: var(--radius); box-shadow: var(--shadow);
}
.timeline-item::before {
  content: ''; position: absolute;
  left: -34px; top: 30px;
  width: 16px; height: 16px;
  background: var(--accent); border-radius: 50%; border: 3px solid var(--bg);
}
.timeline-item h4 { color: var(--primary); font-size: 18px; margin-bottom: 8px; }
.timeline-item p { color: var(--text-light); }
.timeline-item .time-label {
  display: inline-block; background: var(--primary); color: #fff;
  padding: 4px 14px; border-radius: 20px; font-size: 13px; margin-bottom: 10px;
}

.stats-row {
  display: grid;
  grid-template-columns: repeat(auto-fill, minmax(200px, 1fr));
  gap: 20px; margin: 30px 0;
}
.stat-box {
  background: linear-gradient(135deg, var(--card) 0%, #f7fafc 100%);
  border-radius: var(--radius); padding: 24px; text-align: center;
  box-shadow: var(--shadow); border-bottom: 3px solid var(--primary-light);
  transition: var(--transition);
}
.stat-box:nth-child(2) { border-bottom-color: var(--accent); }
.stat-box:nth-child(3) { border-bottom-color: var(--warm); }
.stat-box:nth-child(4) { border-bottom-color: var(--warm-dark); }
.stat-box:hover { transform: translateY(-4px); box-shadow: var(--shadow-hover); }
.stat-box .stat-num {
  font-size: 36px; font-weight: 800;
  background: linear-gradient(135deg, var(--primary), var(--accent));
  -webkit-background-clip: text; -webkit-text-fill-color: transparent; background-clip: text;
}
.stat-box .stat-label { color: var(--text-light); font-size: 14px; margin-top: 6px; }

.carepedia-cta {
  background: linear-gradient(135deg, #1A73E8, #00C9A7);
  padding: 48px 24px; text-align: center; color: #fff;
}
.carepedia-cta h3 { font-size: 24px; font-weight: 700; margin-bottom: 12px; }
.carepedia-cta p { font-size: 16px; opacity: 0.9; margin-bottom: 24px; max-width: 500px; margin-left: auto; margin-right: auto; }
.carepedia-cta .cta-btn {
  display: inline-flex; align-items: center; gap: 8px;
  padding: 14px 32px; background: #fff; color: #1A73E8;
  text-decoration: none; border-radius: 30px; font-size: 16px; font-weight: 700;
  font-family: inherit; transition: all 0.3s ease; box-shadow: 0 4px 16px rgba(0,0,0,0.15);
}
.carepedia-cta .cta-btn:hover { transform: translateY(-2px); box-shadow: 0 8px 24px rgba(0,0,0,0.2); }

.credit-bar {
  display: flex; align-items: center; justify-content: center; gap: 16px; flex-wrap: wrap;
  padding: 14px 20px; font-size: 14px; color: rgba(255,255,255,0.85); position: relative; z-index: 1;
}
.credit-bar span { opacity: 0.9; }
.portal-request-btn {
  display: inline-flex; align-items: center; gap: 8px;
  padding: 10px 22px; background: var(--primary-light); color: #fff;
  text-decoration: none; border-radius: 30px; font-size: 14px;
  font-family: inherit; font-weight: 600; transition: var(--transition);
  box-shadow: 0 2px 12px rgba(0,0,0,0.15);
}
.portal-request-btn:hover { background: var(--primary); transform: translateY(-2px); box-shadow: 0 4px 20px rgba(0,0,0,0.2); }

.footer {
  background: var(--primary); color: rgba(255,255,255,0.8);
  text-align: center; padding: 40px; font-size: 14px;
}

.scroll-top {
  position: fixed; bottom: 30px; left: 30px;
  width: 50px; height: 50px; background: var(--primary);
  color: #fff; border: none; border-radius: 50%;
  font-size: 22px; cursor: pointer; box-shadow: var(--shadow);
  transition: var(--transition); opacity: 0; pointer-events: none; z-index: 999;
}
.scroll-top.visible { opacity: 1; pointer-events: auto; }
.scroll-top:hover { background: var(--primary-light); transform: translateY(-3px); }

.search-box { position: relative; margin: 0 auto; }
.search-box input {
  width: 100%; padding: 14px 20px 14px 50px;
  border: 2px solid rgba(15,76,117,0.15); border-radius: 30px;
  font-size: 16px; font-family: 'Rubik', sans-serif;
  background: var(--card); color: var(--text); transition: var(--transition);
  box-sizing: border-box;
}
.search-box input:focus { outline: none; border-color: var(--primary-light); box-shadow: 0 0 0 4px rgba(50,130,184,0.1); }
.search-box .search-icon {
  position: absolute; left: 18px; top: 50%;
  transform: translateY(-50%); font-size: 20px; pointer-events: none;
}

.sidebar-overlay {
  display: none; position: fixed; top: 0; left: 0; right: 0; bottom: 0;
  background: rgba(0,0,0,0.5); z-index: 999; opacity: 0; transition: opacity 0.3s ease;
}
.sidebar-overlay.active { display: block; opacity: 1; }

@media (max-width: 900px) {
  .sidebar { transform: translateX(-100%); width: 270px; }
  .sidebar.open { transform: translateX(0); }
  .menu-toggle { display: block; }
  .main { margin-left: 0; }
  .hero { padding: 60px 30px; }
  .section { padding: 40px 24px; }
}

@media (max-width: 768px) {
  .sidebar { transform: translateX(-100%); width: 260px; }
  .sidebar.open { transform: translateX(0); }
  .menu-toggle { display: block; }
  .main { margin-left: 0; }
  .hero { padding: 40px 20px 36px; }
  .hero h1 { font-size: 28px; line-height: 1.3; }
  .hero .greeting { font-size: 16px; line-height: 1.7; }
  .hero .subtitle { font-size: 14px; }
  .section { padding: 28px 16px; }
  .section-header { flex-direction: column; align-items: flex-start; gap: 8px; margin-bottom: 24px; padding-bottom: 14px; }
  .section-header .sec-icon { font-size: 32px; }
  .section-header h2 { font-size: 24px; }
  .section-header p { font-size: 14px; }
  .cards-grid { grid-template-columns: 1fr; gap: 16px; margin-bottom: 24px; }
  .card { padding: 20px; }
  .card:hover { transform: none; }
  .cat-card:hover { transform: none; }
  .stat-box:hover { transform: none; }
  .link-btn:hover { transform: none; }
  .portal-request-btn:hover { transform: none; }
  .scroll-top:hover { transform: none; }
  .sidebar nav a:hover { transform: none; }
  .card .card-icon { font-size: 32px; margin-bottom: 10px; }
  .card h3 { font-size: 17px; }
  .card p { font-size: 14px; }
  .cat-grid { grid-template-columns: repeat(2, 1fr); gap: 12px; margin-top: 24px; }
  .cat-card { padding: 18px 12px; }
  .cat-card .cat-icon { font-size: 32px; margin-bottom: 8px; }
  .cat-card h3 { font-size: 14px; }
  .cat-card p { font-size: 11px; }
  .stats-row { grid-template-columns: repeat(2, 1fr); gap: 12px; margin: 20px 0; }
  .stat-box { padding: 16px 10px; }
  .stat-box .stat-num { font-size: 26px; }
  .stat-box .stat-label { font-size: 12px; }
  .tabs { gap: 6px; margin-bottom: 16px; }
  .tab-btn { padding: 8px 14px; font-size: 13px; border-radius: 20px; }
  .styled-table { display: block; overflow-x: auto; -webkit-overflow-scrolling: touch; font-size: 13px; }
  .styled-table th { padding: 10px 12px; font-size: 13px; white-space: nowrap; }
  .styled-table td { padding: 10px 12px; font-size: 13px; min-width: 100px; }
  .info-box { padding: 16px 18px; margin: 16px 0; }
  .info-box h4 { font-size: 15px; }
  .info-box p { font-size: 13px; }
  .accordion-header { padding: 14px 16px; font-size: 15px; }
  .accordion-body .inner { padding: 14px 16px 18px; font-size: 14px; line-height: 1.9; }
  .timeline { padding-left: 30px; margin: 20px 0; }
  .timeline-item { padding: 16px; margin-bottom: 20px; }
  .timeline-item::before { left: -24px; width: 12px; height: 12px; top: 22px; }
  .timeline-item h4 { font-size: 16px; }
  .timeline-item p { font-size: 13px; }
  .link-btn { padding: 10px 16px; font-size: 13px; margin: 4px 2px; }
  .search-box input { padding: 12px 18px 12px 40px; font-size: 14px; }
  .footer { padding: 28px 16px; font-size: 13px; }
  .scroll-top { width: 42px; height: 42px; font-size: 18px; bottom: 20px; left: 16px; }
}

@media (max-width: 380px) {
  .hero h1 { font-size: 24px; }
  .hero .greeting { font-size: 15px; }
  .cat-grid { grid-template-columns: 1fr 1fr; gap: 8px; }
  .cat-card { padding: 14px 8px; }
  .cat-card .cat-icon { font-size: 26px; }
  .cat-card h3 { font-size: 13px; }
  .cat-card p { display: none; }
  .stats-row { grid-template-columns: 1fr 1fr; gap: 8px; }
  .stat-box .stat-num { font-size: 22px; }
  .section { padding: 20px 12px; }
  .tab-btn { padding: 7px 10px; font-size: 12px; }
}

.disclaimer-banner {
  background: linear-gradient(135deg, #FFF3E0, #FFF8E1);
  border-bottom: 2px solid #FFB74D;
  padding: 10px 20px; text-align: center; font-size: 13px; color: #5D4037;
  position: relative; z-index: 1500;
  display: flex; align-items: center; justify-content: center; gap: 8px; flex-wrap: wrap;
}
.disclaimer-banner strong { color: #E65100; }
.disclaimer-banner a { color: #1A73E8; text-decoration: underline; font-weight: 600; }
.disclaimer-banner a:hover { color: #0D47A1; }
@media (max-width: 768px) { .disclaimer-banner { font-size: 12px; padding: 8px 12px; } }
</style>
<script src="https://code.iconify.design/iconify-icon/2.1.0/iconify-icon.min.js" defer></script>
</head>
<body>

<!-- DISCLAIMER BANNER -->
<div class="disclaimer-banner">
  <iconify-icon icon="solar:danger-bold" style="font-size:16px;color:var(--forest);"></iconify-icon>
  <span><strong>This is not medical advice.</strong> Always consult your doctor. <a href="/disclaimer">Full legal disclaimer &rarr;</a></span>
</div>

<!-- SCROLL PROGRESS BAR -->
<div class="scroll-progress"><div class="bar" id="progressBar"></div></div>

<!-- MOBILE OVERLAY -->
<div class="sidebar-overlay" id="sidebarOverlay" onclick="closeMenu()"></div>

<!-- MOBILE MENU TOGGLE -->
<button class="menu-toggle" id="menuToggle" onclick="toggleMenu()"><iconify-icon icon="solar:hamburger-menu-bold"></iconify-icon></button>

<!-- SIDEBAR -->
<aside class="sidebar" id="sidebar">
  <div class="logo">
    <div class="icon"><iconify-icon icon="solar:user-bold-duotone" style="font-size:44px;color:var(--amber);display:block;"></iconify-icon></div>
    <h2>Hair Loss Hub</h2>
  </div>
  <nav>
    <a href="#home" class="active" onclick="navigate(this)"><iconify-icon icon="solar:home-bold" class="nav-icon" style="font-size:20px;"></iconify-icon>Home</a>
    <a href="#about" onclick="navigate(this)"><iconify-icon icon="solar:book-2-bold" class="nav-icon" style="font-size:20px;"></iconify-icon>What is Hair Loss?</a>
    <a href="#types" onclick="navigate(this)"><iconify-icon icon="solar:magnifier-zoom-bold" class="nav-icon" style="font-size:20px;"></iconify-icon>Types &amp; Comparison</a>
    <a href="#treatments" onclick="navigate(this)"><iconify-icon icon="solar:pill-bold" class="nav-icon" style="font-size:20px;"></iconify-icon>Treatments &amp; Medications</a>
    <a href="#trials" onclick="navigate(this)"><iconify-icon icon="solar:test-tube-bold" class="nav-icon" style="font-size:20px;"></iconify-icon>Clinical Trials</a>
    <a href="#research" onclick="navigate(this)"><iconify-icon icon="solar:dna-bold" class="nav-icon" style="font-size:20px;"></iconify-icon>New Research</a>
    <a href="#women" onclick="navigate(this)"><iconify-icon icon="solar:user-heart-bold" class="nav-icon" style="font-size:20px;"></iconify-icon>Hair Loss in Women</a>
    <a href="#transplant" onclick="navigate(this)"><iconify-icon icon="solar:hospital-bold" class="nav-icon" style="font-size:20px;"></iconify-icon>Hair Transplant</a>
    <a href="#natural" onclick="navigate(this)"><iconify-icon icon="solar:leaf-bold" class="nav-icon" style="font-size:20px;"></iconify-icon>Natural Remedies</a>
    <a href="#psychology" onclick="navigate(this)"><iconify-icon icon="solar:brain-bold" class="nav-icon" style="font-size:20px;"></iconify-icon>Psychological Impact</a>
    <a href="#resources" onclick="navigate(this)"><iconify-icon icon="solar:link-bold" class="nav-icon" style="font-size:20px;"></iconify-icon>Links &amp; Resources</a>
  </nav>
</aside>

<!-- MAIN CONTENT -->
<div class="main">

  <!-- HERO -->
  <section class="hero" id="home">
    <div class="credit-bar">
      <span>Built by <strong>Yuval Kashtkir</strong> and his robot assistants</span>
      <a href="https://carepedia.org/en/#contact" target="_blank" class="portal-request-btn">
        ‚ûï Want a portal for another disease?
      </a>
    </div>
    <div class="hero-content">
      <h1>Hair Loss Learning Center</h1>
      <p class="greeting">
        One place with in-depth information, up-to-date research, and practical tools<br>
        for anyone dealing with hair loss and looking for science-based solutions.
      </p>
      <p class="subtitle">
        From approved treatments to the latest breakthroughs. Find quotes from scientific papers, links to research, and practical guides.
      </p>
      <div class="search-box" style="margin-top: 30px; max-width: 600px;">
        <span class="search-icon"><iconify-icon icon="solar:magnifier-bold" style="font-size:18px;color:rgba(255,255,255,0.6);"></iconify-icon></span>
        <input type="text" id="portalSearch" placeholder="Search the portal..." oninput="searchPortal(this.value)">
      </div>
      <div id="searchResults" style="display:none; margin-top: 16px; max-width: 600px;"></div>
    </div>
  </section>

  <!-- QUICK NAVIGATION -->
  <section class="section fade-in" style="padding-bottom: 20px;">
    <div class="cat-grid">
      <a class="cat-card" href="#about" onclick="navigateTo('about')">
        <div class="cat-icon"><iconify-icon icon="solar:book-2-bold" style="font-size:40px;color:var(--forest);"></iconify-icon></div>
        <h3>What is Hair Loss?</h3>
        <p>Basic understanding of the condition</p>
      </a>
      <a class="cat-card" href="#types" onclick="navigateTo('types')">
        <div class="cat-icon"><iconify-icon icon="solar:magnifier-zoom-bold" style="font-size:40px;color:var(--forest);"></iconify-icon></div>
        <h3>Types &amp; Comparison</h3>
        <p>Androgenetic, alopecia areata, telogen and more</p>
      </a>
      <a class="cat-card" href="#treatments" onclick="navigateTo('treatments')">
        <div class="cat-icon"><iconify-icon icon="solar:pill-bold" style="font-size:40px;color:var(--forest);"></iconify-icon></div>
        <h3>Treatments &amp; Medications</h3>
        <p>Approved and innovative medications</p>
      </a>
      <a class="cat-card" href="#trials" onclick="navigateTo('trials')">
        <div class="cat-icon"><iconify-icon icon="solar:test-tube-bold" style="font-size:40px;color:var(--forest);"></iconify-icon></div>
        <h3>Clinical Trials</h3>
        <p>Active research and drugs in development</p>
      </a>
      <a class="cat-card" href="#research" onclick="navigateTo('research')">
        <div class="cat-icon"><iconify-icon icon="solar:dna-bold" style="font-size:40px;color:var(--forest);"></iconify-icon></div>
        <h3>New Research</h3>
        <p>Breakthroughs and discoveries 2025</p>
      </a>
      <a class="cat-card" href="#women" onclick="navigateTo('women')">
        <div class="cat-icon"><iconify-icon icon="solar:user-heart-bold" style="font-size:40px;color:var(--forest);"></iconify-icon></div>
        <h3>Hair Loss in Women</h3>
        <p>Hormonal, postpartum, treatments</p>
      </a>
      <a class="cat-card" href="#transplant" onclick="navigateTo('transplant')">
        <div class="cat-icon"><iconify-icon icon="solar:hospital-bold" style="font-size:40px;color:var(--forest);"></iconify-icon></div>
        <h3>Hair Transplant</h3>
        <p>FUE, FUT, new technologies</p>
      </a>
      <a class="cat-card" href="#natural" onclick="navigateTo('natural')">
        <div class="cat-icon"><iconify-icon icon="solar:leaf-bold" style="font-size:40px;color:var(--forest);"></iconify-icon></div>
        <h3>Natural Remedies</h3>
        <p>Supplements and herbal treatments</p>
      </a>
      <a class="cat-card" href="#psychology" onclick="navigateTo('psychology')">
        <div class="cat-icon"><iconify-icon icon="solar:brain-bold" style="font-size:40px;color:var(--forest);"></iconify-icon></div>
        <h3>Psychological Impact</h3>
        <p>Depression, anxiety and self-image</p>
      </a>
      <a class="cat-card" href="#resources" onclick="navigateTo('resources')">
        <div class="cat-icon"><iconify-icon icon="solar:link-bold" style="font-size:40px;color:var(--forest);"></iconify-icon></div>
        <h3>Links &amp; Resources</h3>
        <p>Organizations, clinics and further information</p>
      </a>
    </div>
  </section>

  <!-- ===== ABOUT SECTION ===== -->
  <section class="section fade-in" id="about">
    <div class="section-header">
      <span class="sec-icon"><iconify-icon icon="solar:book-2-bold" style="font-size:40px;color:var(--forest);"></iconify-icon></span>
      <div>
        <h2>What is Hair Loss?</h2>
        <p>An in-depth understanding of the condition, types, causes, and prevalence</p>
      </div>
    </div>

    <div class="stats-row">
      <div class="stat-box">
        <div class="stat-num">50%</div>
        <div class="stat-label">of men by age 50</div>
      </div>
      <div class="stat-box">
        <div class="stat-num">19%</div>
        <div class="stat-label">of women experience hair loss</div>
      </div>
      <div class="stat-box">
        <div class="stat-num">~2%</div>
        <div class="stat-label">prevalence of alopecia areata</div>
      </div>
      <div class="stat-box">
        <div class="stat-num">80%</div>
        <div class="stat-label">of men by age 70</div>
      </div>
    </div>

    <div class="cards-grid">
      <div class="card">
        <div class="card-icon"><iconify-icon icon="solar:test-tube-bold" style="font-size:36px;color:var(--forest);"></iconify-icon></div>
        <h3>What is Hair Loss?</h3>
        <p>Hair loss (Alopecia) is a condition in which hair falls out from the scalp or other areas of the body. Losing up to 100 hairs per day is considered normal. When shedding exceeds this, or when hair follicles stop producing new hair, it is considered pathological hair loss requiring medical evaluation.</p>
      </div>
      <div class="card green">
        <div class="card-icon"><iconify-icon icon="solar:dna-bold" style="font-size:36px;color:var(--forest);"></iconify-icon></div>
        <h3>Main Causes</h3>
        <p>Causes are varied: genetics (heredity), hormonal changes (DHT, thyroid), autoimmune diseases, psychological stress, nutritional deficiencies (iron, zinc, biotin), medications (chemotherapy, anticoagulants), and environmental factors.</p>
      </div>
      <div class="card orange">
        <div class="card-icon"><iconify-icon icon="solar:danger-bold" style="font-size:36px;color:var(--forest);"></iconify-icon></div>
        <h3>When to See a Doctor</h3>
        <p>When hair loss is sudden and in large amounts, when bald patches appear, when there is itching or pain on the scalp, when hair loss is accompanied by other symptoms (fatigue, weight changes), or when hair loss persists for more than 3 months without improvement.</p>
      </div>
    </div>

    <div class="info-box">
      <h4>The Hair Growth Cycle</h4>
      <p>Each hair has a three-stage life cycle: <strong>Anagen</strong> (growth phase, 2 to 7 years, 85% of hair), <strong>Catagen</strong> (transition phase, 2 to 3 weeks), and <strong>Telogen</strong> (resting and shedding phase, 2 to 3 months). Disruption of this cycle is the basis of most types of hair loss.</p>
    </div>

    <h3 style="color: var(--primary); margin: 30px 0 16px;">Frequently Asked Questions</h3>

    <div class="accordion">
      <div class="accordion-header" onclick="toggleAccordion(this)">
        <span>Is hair loss reversible?</span>
        <span class="arrow">‚ñº</span>
      </div>
      <div class="accordion-body">
        <div class="inner">It depends on the type. Androgenetic hair loss (hereditary) is progressive but can be slowed and sometimes improved with treatment. Alopecia areata (autoimmune) may resolve on its own in 50% of cases within a year. Telogen effluvium (stress-related) usually resolves within 6 to 12 months once the trigger is removed.</div>
      </div>
    </div>
    <div class="accordion">
      <div class="accordion-header" onclick="toggleAccordion(this)">
        <span>Does stress cause hair loss?</span>
        <span class="arrow">‚ñº</span>
      </div>
      <div class="accordion-body">
        <div class="inner">Yes. Acute physical or psychological stress can cause Telogen Effluvium ‚Äî a condition where a large percentage of hair follicles simultaneously enter the shedding phase. This typically occurs 2 to 4 months after the stressful event (surgery, illness, trauma, extreme dieting) and hair regrows when the stress subsides.</div>
      </div>
    </div>
    <div class="accordion">
      <div class="accordion-header" onclick="toggleAccordion(this)">
        <span>What is the best way to get a diagnosis?</span>
        <span class="arrow">‚ñº</span>
      </div>
      <div class="accordion-body">
        <div class="inner">Diagnosis begins with a dermatologist or trichologist. Tests include: a pull test, dermoscopy (trichoscopy) ‚Äî a microscopic examination of the scalp, blood tests (iron, ferritin, thyroid, hormones, vitamin D), and in some cases a scalp biopsy.</div>
      </div>
    </div>
    <div class="accordion">
      <div class="accordion-header" onclick="toggleAccordion(this)">
        <span>Does diet affect hair loss?</span>
        <span class="arrow">‚ñº</span>
      </div>
      <div class="accordion-body">
        <div class="inner">Absolutely. Deficiencies in iron, zinc, biotin (vitamin B7), vitamin D, protein, and essential fatty acids can contribute to hair loss. Extreme diets and nutritional deficits are a recognized cause of telogen effluvium. A balanced diet rich in protein, leafy greens, nuts, and fish supports hair health.</div>
      </div>
    </div>
  </section>

  <!-- ===== TYPES SECTION ===== -->
  <section class="section fade-in" id="types">
    <div class="section-header">
      <span class="sec-icon"><iconify-icon icon="solar:magnifier-zoom-bold" style="font-size:40px;color:var(--forest);"></iconify-icon></span>
      <div>
        <h2>Types of Hair Loss</h2>
        <p>A detailed comparison of the main types</p>
      </div>
    </div>

    <div class="styled-table">
      <table style="width:100%; border-collapse:collapse;">
        <thead>
          <tr>
            <th style="padding:16px 20px; text-align:left; font-weight:600;">Type</th>
            <th style="padding:16px 20px; text-align:left; font-weight:600;">Cause</th>
            <th style="padding:16px 20px; text-align:left; font-weight:600;">Characteristics</th>
            <th style="padding:16px 20px; text-align:left; font-weight:600;">Reversibility</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td style="padding:14px 20px; border-bottom:1px solid #eee; font-weight:600; color:var(--primary);">Androgenetic (AGA)</td>
            <td style="padding:14px 20px; border-bottom:1px solid #eee;">Genetics + DHT hormone</td>
            <td style="padding:14px 20px; border-bottom:1px solid #eee;">Gradual thinning, receding hairline in men, widening part in women</td>
            <td style="padding:14px 20px; border-bottom:1px solid #eee;">Slowed with treatment, not fully reversible</td>
          </tr>
          <tr>
            <td style="padding:14px 20px; border-bottom:1px solid #eee; font-weight:600; color:var(--primary);">Alopecia Areata (AA)</td>
            <td style="padding:14px 20px; border-bottom:1px solid #eee;">Autoimmune</td>
            <td style="padding:14px 20px; border-bottom:1px solid #eee;">Round bald patches, can occur at any age</td>
            <td style="padding:14px 20px; border-bottom:1px solid #eee;">50% regrow within a year; new JAK inhibitors available</td>
          </tr>
          <tr>
            <td style="padding:14px 20px; border-bottom:1px solid #eee; font-weight:600; color:var(--primary);">Telogen Effluvium (TE)</td>
            <td style="padding:14px 20px; border-bottom:1px solid #eee;">Stress, illness, medications</td>
            <td style="padding:14px 20px; border-bottom:1px solid #eee;">Diffuse shedding, 2 to 4 months after a trigger</td>
            <td style="padding:14px 20px; border-bottom:1px solid #eee;">Fully reversible in most cases</td>
          </tr>
          <tr>
            <td style="padding:14px 20px; border-bottom:1px solid #eee; font-weight:600; color:var(--primary);">Alopecia Totalis</td>
            <td style="padding:14px 20px; border-bottom:1px solid #eee;">Severe autoimmune</td>
            <td style="padding:14px 20px; border-bottom:1px solid #eee;">Complete loss of hair on the scalp</td>
            <td style="padding:14px 20px; border-bottom:1px solid #eee;">Difficult to treat; responds to JAK inhibitors</td>
          </tr>
          <tr>
            <td style="padding:14px 20px; border-bottom:1px solid #eee; font-weight:600; color:var(--primary);">Alopecia Universalis</td>
            <td style="padding:14px 20px; border-bottom:1px solid #eee;">Severe autoimmune</td>
            <td style="padding:14px 20px; border-bottom:1px solid #eee;">Complete loss of hair on the entire body</td>
            <td style="padding:14px 20px; border-bottom:1px solid #eee;">Affects ~1% of cases; responds to JAK inhibitors</td>
          </tr>
          <tr>
            <td style="padding:14px 20px; font-weight:600; color:var(--primary);">Scarring Alopecia</td>
            <td style="padding:14px 20px;">Inflammatory, destructive</td>
            <td style="padding:14px 20px;">Irreversible destruction of hair follicles</td>
            <td style="padding:14px 20px;">Not reversible; early treatment is critical</td>
          </tr>
        </tbody>
      </table>
    </div>

    <div class="cards-grid" style="margin-top: 40px;">
      <div class="card">
        <div class="card-icon">üë®</div>
        <h3>Androgenetic Hair Loss in Men</h3>
        <p>The most common type, accounting for 37.7% of all hair loss cases. The hormone DHT (Dihydrotestosterone) gradually shrinks hair follicles. It begins with a receding hairline and thinning at the crown. 50% of men are affected by age 50 and 80% by age 70 (StatPearls, NCBI).</p>
      </div>
      <div class="card green">
        <div class="card-icon">üõ°Ô∏è</div>
        <h3>Alopecia Areata</h3>
        <p>An autoimmune disease in which the immune system attacks hair follicles. It appears as round bald patches. Affects approximately 2% of the global population. 20% of cases occur in children. Higher prevalence in Asian, African, and Latino populations (Nature, 2025).</p>
      </div>
      <div class="card orange">
        <div class="card-icon">‚ö°</div>
        <h3>Telogen Effluvium</h3>
        <p>Temporary hair loss caused by stress. Triggering events include: surgery, acute illness (including COVID), childbirth, extreme dieting, stopping birth control, severe psychological stress. Occurs 2 to 4 months after the trigger. In most cases resolves on its own within 6 to 12 months.</p>
      </div>
    </div>

    <div class="info-box warning">
      <h4>Warning Signs of Scarring Alopecia</h4>
      <p>Scarring alopecia is rare but serious. Signs include: itching or pain on the scalp, redness around hair follicles, scales that cling to the hair root. If these signs are identified ‚Äî seek urgent dermatological care. Early treatment can prevent irreversible follicle destruction.</p>
    </div>
  </section>

  <!-- ===== TREATMENTS SECTION ===== -->
  <section class="section fade-in" id="treatments">
    <div class="section-header">
      <span class="sec-icon"><iconify-icon icon="solar:pill-bold" style="font-size:40px;color:var(--forest);"></iconify-icon></span>
      <div>
        <h2>Treatments &amp; Medications</h2>
        <p>Approved medications, innovative therapies, and what to ask your doctor</p>
      </div>
    </div>

    <div class="tabs" data-tab-group="treatments">
      <button class="tab-btn active" data-tab="approved" onclick="switchTab('treatments','approved')">Approved Medications</button>
      <button class="tab-btn" data-tab="jak" onclick="switchTab('treatments','jak')">JAK Inhibitors</button>
      <button class="tab-btn" data-tab="prp" onclick="switchTab('treatments','prp')">PRP &amp; Other Treatments</button>
      <button class="tab-btn" data-tab="questions" onclick="switchTab('treatments','questions')">Questions for Your Doctor</button>
    </div>

    <!-- TAB: Approved -->
    <div class="tab-content active" data-tab-content="treatments" data-tab="approved">
      <div class="cards-grid">
        <div class="card">
          <div class="card-icon"><iconify-icon icon="solar:pill-bold" style="font-size:36px;color:var(--forest);"></iconify-icon></div>
          <h3>Minoxidil (Rogaine)</h3>
          <p><strong>FDA Approval:</strong> 1988<br><strong>Form:</strong> Topical solution or foam<br><strong>Mechanism:</strong> Dilates blood vessels in the scalp, extends the growth (anagen) phase<br><strong>Efficacy:</strong> A 2022 meta-analysis showed a 12% to 18% increase in hair count after 6 months with 5% concentration<br><strong>For:</strong> Men and women with androgenetic hair loss<br><strong>Side effects:</strong> Local irritation, unwanted facial hair growth (women), low blood pressure (rare)</p>
        </div>
        <div class="card green">
          <div class="card-icon"><iconify-icon icon="solar:pill-bold" style="font-size:36px;color:var(--forest);"></iconify-icon></div>
          <h3>Finasteride (Propecia)</h3>
          <p><strong>FDA Approval:</strong> 1997<br><strong>Form:</strong> Daily pill (1mg)<br><strong>Mechanism:</strong> Inhibits 5-alpha reductase enzyme, reduces DHT by 70%<br><strong>Efficacy:</strong> A long-term study (10 years) showed stabilization or regrowth in 86% of patients<br><strong>For:</strong> Men only (FDA approved)<br><strong>Side effects:</strong> Decreased libido (1% to 2%), erectile dysfunction (rare, reversible)</p>
        </div>
        <div class="card orange">
          <div class="card-icon"><iconify-icon icon="solar:pill-bold" style="font-size:36px;color:var(--forest);"></iconify-icon></div>
          <h3>Dutasteride (Avodart)</h3>
          <p><strong>Approval:</strong> Off-label for hair loss (approved for BPH)<br><strong>Form:</strong> Daily pill (0.5mg)<br><strong>Mechanism:</strong> Inhibits both types of 5-alpha reductase (I and II), more potent than finasteride<br><strong>Efficacy:</strong> Studies show superiority over finasteride in hair count<br><strong>For:</strong> Men who did not respond to finasteride<br><strong>Side effects:</strong> Similar to finasteride, similar frequency</p>
        </div>
      </div>

      <div class="info-box success">
        <h4>New: Low-Dose Oral Minoxidil</h4>
        <p>More and more dermatologists are prescribing low-dose oral minoxidil (0.625mg to 5mg) as an alternative to topical treatment. A biopharmaceutical company is in Phase 3 of clinical trials developing oral minoxidil specifically for hair loss. If approved, this would be the first new prescription medication for patterned hair loss in nearly 30 years.</p>
      </div>
    </div>

    <!-- TAB: JAK Inhibitors -->
    <div class="tab-content" data-tab-content="treatments" data-tab="jak">
      <div class="info-box">
        <h4>The JAK Inhibitor Revolution for Alopecia Areata</h4>
        <p>Since 2022, the FDA has approved three JAK inhibitors for the treatment of severe alopecia areata. These are the first medications approved specifically for this disease, and they represent a genuine revolution.</p>
      </div>

      <div class="cards-grid">
        <div class="card">
          <div class="card-icon">üü¢</div>
          <h3>Baricitinib (Olumiant)</h3>
          <p><strong>Approval:</strong> June 2022, the first approved<br><strong>Form:</strong> Daily pill, JAK1/JAK2 inhibitor<br><strong>Efficacy:</strong> 32% to 35% of patients achieved 80% or more scalp coverage after 36 weeks (4mg dose)<br><strong>For:</strong> Adults with severe alopecia areata</p>
        </div>
        <div class="card green">
          <div class="card-icon">üü¢</div>
          <h3>Ritlecitinib (Litfulo)</h3>
          <p><strong>Approval:</strong> June 2023<br><strong>Form:</strong> Daily pill, JAK3/TEC inhibitor<br><strong>Efficacy:</strong> 40% of patients achieved 80% or more scalp coverage after 48 weeks<br><strong>For:</strong> Ages 12 and older ‚Äî the first medication approved for adolescents as well</p>
        </div>
        <div class="card orange">
          <div class="card-icon">üü¢</div>
          <h3>Deuruxolitinib (Leqselvi)</h3>
          <p><strong>Approval:</strong> 2024<br><strong>Form:</strong> Daily pill (8mg), JAK1/JAK2 inhibitor<br><strong>Efficacy:</strong> Over 30% achieved 80% or more coverage after 24 weeks; up to 25% achieved 90% or more coverage<br><strong>For:</strong> Adults with severe alopecia areata</p>
        </div>
      </div>

      <div class="info-box warning">
        <h4>Important to Know About JAK Inhibitors</h4>
        <p>JAK inhibitors are immunosuppressive medications. Possible side effects include: upper respiratory tract infections, headaches, acne, elevated cholesterol. Periodic blood monitoring is required. These medications do not cure the disease ‚Äî hair loss may return if treatment is stopped.</p>
      </div>
    </div>

    <!-- TAB: PRP -->
    <div class="tab-content" data-tab-content="treatments" data-tab="prp">
      <div class="cards-grid">
        <div class="card">
          <div class="card-icon">ü©∏</div>
          <h3>PRP ‚Äî Platelet-Rich Plasma</h3>
          <p><strong>What it is:</strong> A treatment using the patient's own plasma, enriched with growth factors<br><strong>Process:</strong> Blood draw ‚Üí centrifugation ‚Üí injection into the scalp<br><strong>Efficacy:</strong> Studies show improvement in hair density and thickness, especially combined with other treatments<br><strong>Frequency:</strong> A series of 3 to 4 treatments one month apart, then maintenance every 3 to 6 months</p>
        </div>
        <div class="card green">
          <div class="card-icon">üíâ</div>
          <h3>Corticosteroid Injections</h3>
          <p><strong>For:</strong> Primarily for alopecia areata (bald patches)<br><strong>What it is:</strong> Injection of corticosteroids directly into the bald area<br><strong>Efficacy:</strong> High for limited patches; hair regrows within 4 to 8 weeks<br><strong>Limitation:</strong> Not suitable for large areas; may cause local skin thinning</p>
        </div>
        <div class="card orange">
          <div class="card-icon">‚ö°</div>
          <h3>Low-Level Laser Therapy (LLLT)</h3>
          <p><strong>What it is:</strong> Home devices (helmets, combs) that emit low-level laser light<br><strong>Mechanism:</strong> Increases blood flow and cellular activity in follicles<br><strong>Efficacy:</strong> FDA-cleared as a medical device; studies show modest improvement<br><strong>For:</strong> As a complement to other treatments, not as a standalone therapy</p>
        </div>
      </div>
    </div>

    <!-- TAB: Questions -->
    <div class="tab-content" data-tab-content="treatments" data-tab="questions">
      <div class="info-box">
        <h4>Important Questions for Your Doctor Visit</h4>
        <p>Being prepared for your appointment can make a real difference. Here are questions worth asking:</p>
      </div>
      <div class="cards-grid">
        <div class="card">
          <div class="card-icon">1Ô∏è‚É£</div>
          <h3>Diagnosis</h3>
          <p>What is the exact type of my hair loss? Do I need additional tests (blood tests, biopsy)? Is there an underlying medical condition that needs to be treated?</p>
        </div>
        <div class="card green">
          <div class="card-icon">2Ô∏è‚É£</div>
          <h3>Treatment</h3>
          <p>What treatment options are relevant to my condition? When can I expect to see results? What happens if I stop treatment? Are there new medications worth considering?</p>
        </div>
        <div class="card orange">
          <div class="card-icon">3Ô∏è‚É£</div>
          <h3>Expectations</h3>
          <p>What is a realistic prognosis for my situation? Is the hair loss expected to continue? Is a hair transplant right for me? What are the risks and benefits of each option?</p>
        </div>
      </div>
    </div>
  </section>

  <!-- ===== CLINICAL TRIALS SECTION ===== -->
  <section class="section fade-in" id="trials">
    <div class="section-header">
      <span class="sec-icon"><iconify-icon icon="solar:test-tube-bold" style="font-size:40px;color:var(--forest);"></iconify-icon></span>
      <div>
        <h2>Clinical Trials</h2>
        <p>Drugs in development and active research shaping the future</p>
      </div>
    </div>

    <div class="timeline">
      <div class="timeline-item">
        <span class="time-label">Phase 3 ‚Äî Expected approval 2026</span>
        <h4>Clascoterone 5% (Cosmo Pharmaceuticals)</h4>
        <p>The first topical androgen receptor inhibitor of its kind for androgenetic hair loss in men. In two identical Phase 3 studies, it showed improvements of 539% and 168% in hair count (TAHC) compared to placebo. Cosmo is expected to submit for FDA and EMA approval in spring 2026 (Dermatology Times, December 2025).</p>
      </div>
      <div class="timeline-item">
        <span class="time-label">Phase 2a ‚Äî Phase 3 planned for 2026</span>
        <h4>PP405 (Pelage Pharmaceuticals / UCLA)</h4>
        <p>A small molecule that awakens dormant stem cells in hair follicles. In Phase 2a, 31% of patients showed a 20% or greater increase in density. Pelage raised $120 million (Series B, October 2025) to advance Phase 3 in 2026. If approved, this would be the first treatment to restore dormant follicles (UCLA Newsroom).</p>
      </div>
      <div class="timeline-item">
        <span class="time-label">Phase 3 ‚Äî Completed</span>
        <h4>Oral Minoxidil (Phase 3)</h4>
        <p>A biopharmaceutical company completed Phase 3 for oral minoxidil specifically designed for patterned hair loss in men and women. If approved, this would be the first new prescription medication for hair loss in approximately 30 years (American Salon, 2025).</p>
      </div>
      <div class="timeline-item">
        <span class="time-label">Advanced Research</span>
        <h4>Exosome and Stem Cell Therapies</h4>
        <p>Exosome therapy and secretome represent a new generation of regenerative medicine. These are tiny vesicles containing growth factors, peptides, and proteins that communicate directly with follicle cells. Shiseido launched in Japan (July 2024) an autologous stem cell (DSC)-based treatment with promising results.</p>
      </div>
      <div class="timeline-item">
        <span class="time-label">Future ‚Äî 2026 to 2028</span>
        <h4>Gene Therapy and Antibody Treatments</h4>
        <p>Researchers are developing gene therapies targeting specific molecular pathways involved in the hair growth cycle. Antibody therapies offer high precision in targeting key pathways. Regenerative treatments based on autologous stem cells may enter early commercialization by late 2026 (BioInformant).</p>
      </div>
    </div>

    <div class="info-box success">
      <h4>How to Find Clinical Trials</h4>
      <p>The website <a href="https://clinicaltrials.gov" target="_blank" style="color:var(--primary); font-weight:600;">ClinicalTrials.gov</a> is the world's largest registry. Search for "alopecia" or "hair loss" and filter by location and status (Recruiting). Major academic medical centers worldwide regularly participate in international hair loss trials.</p>
    </div>
  </section>

  <!-- ===== RESEARCH SECTION ===== -->
  <section class="section fade-in" id="research">
    <div class="section-header">
      <span class="sec-icon"><iconify-icon icon="solar:dna-bold" style="font-size:40px;color:var(--forest);"></iconify-icon></span>
      <div>
        <h2>New Research</h2>
        <p>Scientific breakthroughs from 2025 and 2026</p>
      </div>
    </div>

    <div class="cards-grid">
      <div class="card">
        <div class="card-icon">üß™</div>
        <h3>PP405 Molecule ‚Äî UCLA</h3>
        <p>Scientists at UCLA identified a small molecule that can awaken dormant but intact hair follicles. Unlike existing treatments that slow shedding, PP405 targets the restoration of active growth. First human trials (Orange County) showed very encouraging results (UCLA Newsroom, 2025).</p>
      </div>
      <div class="card green">
        <div class="card-icon">ü§ñ</div>
        <h3>AI for Early Diagnosis</h3>
        <p>In 2025, startups and dermatology platforms began deploying AI systems to analyze scalp and hair via smartphone photos. The systems detect early signs of alopecia before hair loss is visible to the naked eye ‚Äî enabling earlier and more effective intervention (Hair Loss Review Centre, 2026).</p>
      </div>
      <div class="card orange">
        <div class="card-icon">ü¶†</div>
        <h3>The Scalp Microbiome</h3>
        <p>New research is investigating the link between the composition of scalp bacteria and hair health. 2026 is marked as "the year of the microbiome" in the hair field, with discoveries about how specific bacteria affect local inflammation and the follicle life cycle (Hair Loss Review Centre).</p>
      </div>
    </div>

    <div class="cards-grid">
      <div class="card">
        <div class="card-icon">üíâ</div>
        <h3>Stem Cells ‚Äî Shiseido in Japan</h3>
        <p>Shiseido launched in July 2024 in Japan a regenerative stem cell-based treatment: extraction of DSC (Dermal Sheath Cup) cells from the patient, laboratory multiplication, and injection back into the scalp. Clinical studies demonstrated safety and efficacy in androgenetic hair loss in both men and women (BioInformant, 2026).</p>
      </div>
      <div class="card green">
        <div class="card-icon"><iconify-icon icon="solar:dna-bold" style="font-size:36px;color:var(--forest);"></iconify-icon></div>
        <h3>Clascoterone ‚Äî Topical Androgen Inhibitor</h3>
        <p>Two large Phase 3 studies proved that Clascoterone 5% solution is significantly effective in androgenetic hair loss in men. The mechanism: direct blockade of androgen receptors in the scalp, without systemic effects. FDA submission expected in spring 2026 (STAT News, December 2025).</p>
      </div>
      <div class="card orange">
        <div class="card-icon"><iconify-icon icon="solar:pill-bold" style="font-size:36px;color:var(--forest);"></iconify-icon></div>
        <h3>GLP-1 and Hair Loss?</h3>
        <p>GLP-1 medications (such as Ozempic and Wegovy) are now being studied in the context of hair. An article in Drug Discovery News (2025) asked: "Could hair loss become the next GLP-1 moment?" ‚Äî referring to massive investment in a field with enormous market potential.</p>
      </div>
    </div>

    <div class="info-box">
      <h4>Up-to-Date Research Sources</h4>
      <p>All information in this portal is based on papers from PMC/PubMed, STAT News, Dermatology Times, Nature Scientific Reports, BioInformant, UCLA Newsroom, and clinical trials registered at ClinicalTrials.gov. Publication dates: 2024 to 2026.</p>
    </div>
  </section>

  <!-- ===== WOMEN SECTION ===== -->
  <section class="section fade-in" id="women">
    <div class="section-header">
      <span class="sec-icon"><iconify-icon icon="solar:user-heart-bold" style="font-size:40px;color:var(--forest);"></iconify-icon></span>
      <div>
        <h2>Hair Loss in Women</h2>
        <p>Hormonal causes, postpartum hair loss, and targeted treatments</p>
      </div>
    </div>

    <div class="stats-row">
      <div class="stat-box">
        <div class="stat-num">19%</div>
        <div class="stat-label">of women experience FPHL</div>
      </div>
      <div class="stat-box">
        <div class="stat-num">40-50%</div>
        <div class="stat-label">experience postpartum hair loss</div>
      </div>
      <div class="stat-box">
        <div class="stat-num">88%</div>
        <div class="stat-label">reported impact on daily life</div>
      </div>
      <div class="stat-box">
        <div class="stat-num">75%</div>
        <div class="stat-label">reported damage to self-confidence</div>
      </div>
    </div>

    <div class="cards-grid">
      <div class="card">
        <div class="card-icon"><iconify-icon icon="solar:test-tube-bold" style="font-size:36px;color:var(--forest);"></iconify-icon></div>
        <h3>Female Pattern Hair Loss (FPHL)</h3>
        <p>Different from the male pattern: manifests as diffuse thinning and widening of the part, usually without a receding hairline. Triggers: genetics, androgen sensitivity, menopause, polycystic ovary syndrome (PCOS). Treatment: Minoxidil 2% or 5% (FDA-approved for women), spironolactone (the most common anti-androgen, off-label).</p>
      </div>
      <div class="card green">
        <div class="card-icon">ü§∞</div>
        <h3>Postpartum Hair Loss</h3>
        <p>Occurs in 40% to 50% of women. <strong>Reason:</strong> During pregnancy, high estrogen levels extend the growth phase. After delivery, hormones return to normal and a large amount of hair simultaneously enters the shedding phase. <strong>Timing:</strong> Begins 3 to 4 months after delivery, lasts up to 12 months. <strong>Important:</strong> This is a temporary and natural phenomenon (Cleveland Clinic, Johns Hopkins).</p>
      </div>
      <div class="card orange">
        <div class="card-icon">‚öñÔ∏è</div>
        <h3>Other Hormonal Causes</h3>
        <p><strong>Thyroid gland:</strong> Both underactive and overactive thyroid cause hair loss.<br><strong>Birth control pills:</strong> Starting or stopping can trigger telogen effluvium.<br><strong>Menopause:</strong> Decline in estrogen and relative increase in androgens.<br><strong>PCOS:</strong> Excess androgens, hair loss combined with excess body hair.</p>
      </div>
    </div>

    <div class="info-box">
      <h4>Approved Treatments for Women</h4>
      <p><strong>Minoxidil:</strong> FDA-approved for women (2% and 5%). <strong>Spironolactone:</strong> The most common anti-androgen for female hair loss (off-label, PMC 2018). <strong>PRP:</strong> Especially effective combined with minoxidil. <strong>Iron and Vitamin D supplements:</strong> Essential when deficient (common after childbirth and breastfeeding). <strong>Important:</strong> Finasteride is contraindicated in women of childbearing age (risk of fetal harm).</p>
    </div>

    <div class="accordion">
      <div class="accordion-header" onclick="toggleAccordion(this)">
        <span>When does postpartum hair loss require medical evaluation?</span>
        <span class="arrow">‚ñº</span>
      </div>
      <div class="accordion-body">
        <div class="inner">If hair loss persists beyond 12 months after delivery, if it is very severe, if accompanied by extreme fatigue, or if bald patches appear ‚Äî check iron, ferritin, thyroid, vitamin D, and B12 levels. Nutritional deficiency during breastfeeding is a common and treatable cause.</div>
      </div>
    </div>
    <div class="accordion">
      <div class="accordion-header" onclick="toggleAccordion(this)">
        <span>Is minoxidil safe during breastfeeding?</span>
        <span class="arrow">‚ñº</span>
      </div>
      <div class="accordion-body">
        <div class="inner">There is insufficient research on the safety of minoxidil during breastfeeding, and therefore most doctors recommend waiting until breastfeeding ends. In the meantime, focus on proper nutrition, iron and vitamin D supplements (with medical guidance), and PRP treatments (which use the patient's own blood).</div>
      </div>
    </div>
  </section>

  <!-- ===== HAIR TRANSPLANT SECTION ===== -->
  <section class="section fade-in" id="transplant">
    <div class="section-header">
      <span class="sec-icon"><iconify-icon icon="solar:hospital-bold" style="font-size:40px;color:var(--forest);"></iconify-icon></span>
      <div>
        <h2>Hair Transplant</h2>
        <p>Techniques, success rates, costs, and what you need to know</p>
      </div>
    </div>

    <div class="stats-row">
      <div class="stat-box">
        <div class="stat-num">95-98%</div>
        <div class="stat-label">graft survival rate (2026)</div>
      </div>
      <div class="stat-box">
        <div class="stat-num">60%</div>
        <div class="stat-label">of transplants are FUE</div>
      </div>
      <div class="stat-box">
        <div class="stat-num">12-18</div>
        <div class="stat-label">months for full results</div>
      </div>
    </div>

    <div class="tabs" data-tab-group="transplant">
      <button class="tab-btn active" data-tab="fue" onclick="switchTab('transplant','fue')">FUE</button>
      <button class="tab-btn" data-tab="fut" onclick="switchTab('transplant','fut')">FUT</button>
      <button class="tab-btn" data-tab="compare" onclick="switchTab('transplant','compare')">Comparison</button>
    </div>

    <div class="tab-content active" data-tab-content="transplant" data-tab="fue">
      <div class="card" style="margin-bottom: 24px;">
        <h3>FUE ‚Äî Follicular Unit Extraction</h3>
        <p><strong>What it is:</strong> Extraction of individual follicular units from the donor area (usually the back of the head) using a microscopic device, and transplanting them into the bald area.<br><strong>Advantages:</strong> No linear scar, faster recovery (5 to 7 days), suitable for short haircuts.<br><strong>Disadvantages:</strong> More expensive than FUT, longer procedure time, fewer grafts in a single session.<br><strong>Cost:</strong> $4 to $10 per graft, total $6,000 to $15,000.<br><strong>New technologies:</strong> ARTAS robotic system, NeoGraft device, SAFE system, and PCID system reduce complications and increase precision.</p>
      </div>
    </div>

    <div class="tab-content" data-tab-content="transplant" data-tab="fut">
      <div class="card" style="margin-bottom: 24px;">
        <h3>FUT ‚Äî Follicular Unit Transplantation (Strip)</h3>
        <p><strong>What it is:</strong> Removal of a narrow strip of skin from the back of the head, cutting it into micro-units, and transplanting them into the bald area.<br><strong>Advantages:</strong> More grafts can be transplanted in a single session, lower cost per graft.<br><strong>Disadvantages:</strong> Linear scar at the back of the head, longer recovery (10 to 14 days).<br><strong>Cost:</strong> $3 to $7 per graft, total $4,000 to $15,000.</p>
      </div>
    </div>

    <div class="tab-content" data-tab-content="transplant" data-tab="compare">
      <div class="styled-table">
        <table style="width:100%; border-collapse:collapse;">
          <thead>
            <tr>
              <th style="padding:16px 20px; text-align:left; font-weight:600;">Criterion</th>
              <th style="padding:16px 20px; text-align:left; font-weight:600;">FUE</th>
              <th style="padding:16px 20px; text-align:left; font-weight:600;">FUT</th>
            </tr>
          </thead>
          <tbody>
            <tr><td style="padding:14px 20px; border-bottom:1px solid #eee; font-weight:600;">Scar</td><td style="padding:14px 20px; border-bottom:1px solid #eee;">Tiny dots</td><td style="padding:14px 20px; border-bottom:1px solid #eee;">Linear line</td></tr>
            <tr><td style="padding:14px 20px; border-bottom:1px solid #eee; font-weight:600;">Recovery</td><td style="padding:14px 20px; border-bottom:1px solid #eee;">5 to 7 days</td><td style="padding:14px 20px; border-bottom:1px solid #eee;">10 to 14 days</td></tr>
            <tr><td style="padding:14px 20px; border-bottom:1px solid #eee; font-weight:600;">Grafts per session</td><td style="padding:14px 20px; border-bottom:1px solid #eee;">Up to 4,000</td><td style="padding:14px 20px; border-bottom:1px solid #eee;">Up to 5,000+</td></tr>
            <tr><td style="padding:14px 20px; border-bottom:1px solid #eee; font-weight:600;">Graft survival</td><td style="padding:14px 20px; border-bottom:1px solid #eee;">95% to 98%</td><td style="padding:14px 20px; border-bottom:1px solid #eee;">95% to 98%</td></tr>
            <tr><td style="padding:14px 20px; font-weight:600;">Cost per graft</td><td style="padding:14px 20px;">$4 to $10</td><td style="padding:14px 20px;">$3 to $7</td></tr>
          </tbody>
        </table>
      </div>
    </div>

    <div class="info-box warning">
      <h4>When is a Hair Transplant Not Recommended?</h4>
      <p>A transplant is not recommended when: hair loss is not yet stable (wait for stabilization), there is insufficient donor hair, you have active alopecia areata (the immune system may attack transplanted grafts too), expectations are not realistic, or when the cause is nutritional or hormonal and can be treated otherwise.</p>
    </div>
  </section>

  <!-- ===== NATURAL REMEDIES SECTION ===== -->
  <section class="section fade-in" id="natural">
    <div class="section-header">
      <span class="sec-icon"><iconify-icon icon="solar:leaf-bold" style="font-size:40px;color:var(--forest);"></iconify-icon></span>
      <div>
        <h2>Natural Remedies &amp; Supplements</h2>
        <p>What science says about natural treatments for hair loss</p>
      </div>
    </div>

    <div class="info-box">
      <h4>Disclosure</h4>
      <p>Supplements and natural treatments are not a substitute for medical treatment. The efficacy of some is supported by research, but the level of evidence is lower than that of prescription medications. Consult a doctor before starting any treatment.</p>
    </div>

    <div class="cards-grid">
      <div class="card">
        <div class="card-icon">üå¥</div>
        <h3>Saw Palmetto</h3>
        <p><strong>Mechanism:</strong> Inhibits 5-alpha reductase, reduces DHT (similar to finasteride, but weaker).<br><strong>Studies:</strong> 5 randomized controlled trials and 2 cohort studies showed: 60% improvement in hair quality, 27% increase in hair count, increased density in 83.3% of patients (PMC, 2020).<br><strong>Dose:</strong> 100 to 320 mg per day.<br><strong>Evidence level:</strong> Moderate ‚Äî the best among natural remedies.</p>
      </div>
      <div class="card green">
        <div class="card-icon">ü´í</div>
        <h3>Rosemary Oil</h3>
        <p><strong>Mechanism:</strong> Contains rosmarinic acid, camphor, and anti-inflammatory compounds that increase blood flow to the scalp.<br><strong>Studies:</strong> Research shows efficacy comparable to 2% minoxidil as a topical treatment, with fewer side effects (PMC, 2024).<br><strong>Use:</strong> Massage diluted in a carrier oil, 2 to 3 times per week.<br><strong>Evidence level:</strong> Moderate.</p>
      </div>
      <div class="card orange">
        <div class="card-icon">üéÉ</div>
        <h3>Pumpkin Seed Oil</h3>
        <p><strong>Mechanism:</strong> Beta-sitosterol and linolenic acid inhibit 5-alpha reductase and reduce inflammation (IL-6).<br><strong>Studies:</strong> A randomized double-blind trial (PMC, 2014) showed a 40% increase in hair count after 24 weeks versus placebo.<br><strong>Dose:</strong> 400 mg per day (capsules) or topical use.<br><strong>Evidence level:</strong> Limited, based on one key study.</p>
      </div>
    </div>

    <div class="cards-grid">
      <div class="card">
        <div class="card-icon"><iconify-icon icon="solar:pill-bold" style="font-size:36px;color:var(--forest);"></iconify-icon></div>
        <h3>Biotin (Vitamin B7)</h3>
        <p><strong>Mechanism:</strong> Essential for keratin production.<br><strong>The truth:</strong> Effective only when there is a proven deficiency (rare in the general population). If biotin levels are normal, supplementation will not improve hair loss. <strong>Important:</strong> Biotin interferes with blood tests (thyroid, troponin) ‚Äî stop 72 hours before testing.<br><strong>Evidence level:</strong> Weak for general hair loss, strong only in deficiency.</p>
      </div>
      <div class="card green">
        <div class="card-icon">ü•ú</div>
        <h3>Nutrition &amp; Minerals</h3>
        <p><strong>Iron:</strong> Iron deficiency is a common cause of hair loss, especially in women. Check ferritin levels.<br><strong>Zinc:</strong> Essential for follicle function; deficiency is common in restrictive diets.<br><strong>Vitamin D:</strong> Deficiency is associated with alopecia areata.<br><strong>Protein:</strong> Hair is 90% keratin (protein). Low-protein diets cause hair loss.<br><strong>Omega-3:</strong> Anti-inflammatory properties that support scalp health.</p>
      </div>
      <div class="card orange">
        <div class="card-icon">‚òï</div>
        <h3>Caffeine &amp; Melatonin</h3>
        <p><strong>Caffeine:</strong> Studies show that topical caffeine promotes hair follicle growth and counteracts the inhibitory effect of DHT in the laboratory. Caffeine-based shampoos are commercially available.<br><strong>Melatonin:</strong> Topical melatonin solutions have shown promising results in several studies on androgenetic hair loss (PMC, 2024).</p>
      </div>
    </div>
  </section>

  <!-- ===== PSYCHOLOGY SECTION ===== -->
  <section class="section fade-in" id="psychology">
    <div class="section-header">
      <span class="sec-icon"><iconify-icon icon="solar:brain-bold" style="font-size:40px;color:var(--forest);"></iconify-icon></span>
      <div>
        <h2>The Psychological Impact</h2>
        <p>Depression, anxiety, self-image and coping strategies</p>
      </div>
    </div>

    <div class="stats-row">
      <div class="stat-box">
        <div class="stat-num">88%</div>
        <div class="stat-label">reported negative impact on daily life</div>
      </div>
      <div class="stat-box">
        <div class="stat-num">75%</div>
        <div class="stat-label">reported damage to self-confidence</div>
      </div>
      <div class="stat-box">
        <div class="stat-num">50%</div>
        <div class="stat-label">reported social difficulties</div>
      </div>
    </div>

    <div class="cards-grid">
      <div class="card">
        <div class="card-icon">üòî</div>
        <h3>Anxiety &amp; Depression</h3>
        <p>A systematic review (PMC, 2023) found that androgenetic hair loss is a significant psychosocial stressor. Common symptoms include: anxiety, anger, depression, embarrassment, loss of self-confidence, social withdrawal, and in extreme cases, suicidal thoughts. The link between hair loss and anxiety is statistically significant (meta-analysis, PMC 2025).</p>
      </div>
      <div class="card green">
        <div class="card-icon">üë©‚Äçü¶∞</div>
        <h3>Impact on Women</h3>
        <p>Women report higher levels of anxiety than men in the context of hair loss. The impact is especially strong in women with non-scarring alopecia, who reported difficulties in personal relationships and daily functioning. 88% of women who sought treatment reported a negative impact on daily life, and 75% reported damage to self-confidence (AJMC).</p>
      </div>
      <div class="card orange">
        <div class="card-icon">üë¶</div>
        <h3>Impact on Young People</h3>
        <p>Younger and middle-aged patients reported greater quality-of-life impairment and higher anxiety levels than older adults. This makes sense ‚Äî hair carries greater aesthetic and identity value at a younger age. 20% of alopecia areata cases are in children, adding unique social challenges (Yale Medicine).</p>
      </div>
    </div>

    <div class="info-box success">
      <h4>What Helps?</h4>
      <p>Research from 2025 shows that supportive interventions such as <strong>body image therapy</strong>, <strong>group counseling</strong>, and <strong>structured psychosocial support programs</strong> significantly reduce emotional distress among people dealing with chronic hair loss (PMC, 2025). Support groups (online and in-person) are also reported as highly effective.</p>
    </div>

    <div class="accordion">
      <div class="accordion-header" onclick="toggleAccordion(this)">
        <span>Does psychological therapy really help?</span>
        <span class="arrow">‚ñº</span>
      </div>
      <div class="accordion-body">
        <div class="inner">Yes. Research shows that CBT (Cognitive Behavioral Therapy) and ACT (Acceptance and Commitment Therapy) are effective in reducing anxiety and depression related to hair loss. Therapy does not restore hair, but it changes the way we cope with the loss and allows for a fuller life.</div>
      </div>
    </div>
    <div class="accordion">
      <div class="accordion-header" onclick="toggleAccordion(this)">
        <span>How do you talk to children about hair loss?</span>
        <span class="arrow">‚ñº</span>
      </div>
      <div class="accordion-body">
        <div class="inner">Speak at their level and explain that it is a disease and not the child's fault. Help the child prepare answers for friends' questions. Consider a support group for children with alopecia. Work with the school to create a supportive environment. The National Alopecia Areata Foundation (NAAF) offers dedicated resources for children and families.</div>
      </div>
    </div>
  </section>

  <!-- ===== RESOURCES SECTION ===== -->
  <section class="section fade-in" id="resources">
    <div class="section-header">
      <span class="sec-icon"><iconify-icon icon="solar:link-bold" style="font-size:40px;color:var(--forest);"></iconify-icon></span>
      <div>
        <h2>Links &amp; Resources</h2>
        <p>International organizations, research tools, and key information</p>
      </div>
    </div>

    <h3 style="color: var(--primary); margin-bottom: 20px;">Leading International Organizations</h3>
    <div class="cards-grid">
      <div class="card green">
        <h3>National Alopecia Areata Foundation (NAAF)</h3>
        <p>The world's leading organization for alopecia areata research and support. Provides information, research funding, community, and support groups for patients and families worldwide.</p>
        <a href="https://www.naaf.org/" target="_blank" class="link-btn green" style="margin-top: 10px;">naaf.org</a>
      </div>
      <div class="card blue">
        <h3>Alopecia UK</h3>
        <p>A UK-based charity supporting people affected by alopecia. Offers helplines, support groups, information resources, and advocacy for better treatment access.</p>
        <a href="https://www.alopecia.org.uk/" target="_blank" class="link-btn" style="margin-top: 10px;">alopecia.org.uk</a>
      </div>
      <div class="card orange">
        <h3>Alopecia World</h3>
        <p>A global online community for people living with all forms of alopecia. Connects patients worldwide for peer support, information sharing, and community building.</p>
        <a href="https://www.alopeciaworld.com/" target="_blank" class="link-btn orange" style="margin-top: 10px;">alopeciaworld.com</a>
      </div>
      <div class="card">
        <h3>American Academy of Dermatology (AAD)</h3>
        <p>The leading professional organization for dermatologists. Provides patient education resources, treatment guidelines, and a dermatologist locator tool.</p>
        <a href="https://www.aad.org/public/diseases/hair-loss" target="_blank" class="link-btn" style="margin-top: 10px;">aad.org</a>
      </div>
    </div>

    <h3 style="color: var(--primary); margin: 40px 0 20px;">Research &amp; Search Tools</h3>
    <div class="cards-grid">
      <div class="card">
        <h3>ClinicalTrials.gov</h3>
        <p>The world's largest registry of clinical trials. Search "alopecia" or "hair loss" and filter by status (Recruiting) to find active trials worldwide.</p>
        <a href="https://clinicaltrials.gov/search?cond=alopecia&status=RECRUITING" target="_blank" class="link-btn" style="margin-top: 10px;">Find Trials</a>
      </div>
      <div class="card green">
        <h3>PubMed ‚Äî Research Papers</h3>
        <p>The world's largest database of medical research. Search for the latest hair loss and alopecia studies.</p>
        <a href="https://pubmed.ncbi.nlm.nih.gov/?term=alopecia+hair+loss&sort=date" target="_blank" class="link-btn green" style="margin-top: 10px;">PubMed</a>
      </div>
      <div class="card blue">
        <h3>DermNet NZ</h3>
        <p>A comprehensive, peer-reviewed dermatology resource covering all types of hair loss with patient-friendly and clinical information.</p>
        <a href="https://dermnetnz.org/topics/hair-loss" target="_blank" class="link-btn" style="margin-top: 10px;">DermNet NZ</a>
      </div>
      <div class="card orange">
        <h3>Hair Loss Review Centre</h3>
        <p>An independent resource reviewing treatments, research, and news in the hair loss field. Covers the latest breakthroughs and clinical developments.</p>
        <a href="https://hairlossreview.org/" target="_blank" class="link-btn orange" style="margin-top: 10px;">Hair Loss Review</a>
      </div>
    </div>

    <h3 style="color: var(--primary); margin: 40px 0 20px;">Key Research Articles</h3>
    <div class="cards-grid">
      <div class="card">
        <h3>Approved Treatments</h3>
        <ul style="padding-left: 16px; font-size: 14px; color: var(--text-light);">
          <li><a href="https://pubmed.ncbi.nlm.nih.gov/19364163/" target="_blank">Minoxidil meta-analysis ‚Äî PMC Review</a> ‚Äî efficacy and safety</li>
          <li><a href="https://pubmed.ncbi.nlm.nih.gov/9777765/" target="_blank">Finasteride 10-year study ‚Äî NEJM</a> ‚Äî long-term outcomes</li>
          <li><a href="https://pubmed.ncbi.nlm.nih.gov/35187655/" target="_blank">Baricitinib for Alopecia Areata ‚Äî NEJM 2022</a></li>
          <li><a href="https://pubmed.ncbi.nlm.nih.gov/37191124/" target="_blank">Ritlecitinib ‚Äî NEJM 2023</a></li>
        </ul>
      </div>
      <div class="card green">
        <h3>Natural Remedies</h3>
        <ul style="padding-left: 16px; font-size: 14px; color: var(--text-light);">
          <li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7271951/" target="_blank">Saw Palmetto review ‚Äî PMC, 2020</a></li>
          <li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11030666/" target="_blank">Rosemary oil vs. minoxidil ‚Äî PMC, 2024</a></li>
          <li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4017725/" target="_blank">Pumpkin Seed Oil RCT ‚Äî PMC, 2014</a></li>
        </ul>
      </div>
      <div class="card orange">
        <h3>Psychological Impact</h3>
        <ul style="padding-left: 16px; font-size: 14px; color: var(--text-light);">
          <li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10374888/" target="_blank">Psychosocial impact of hair loss ‚Äî PMC, 2023</a></li>
          <li><a href="https://pubmed.ncbi.nlm.nih.gov/33460053/" target="_blank">Anxiety and AGA ‚Äî meta-analysis, 2021</a></li>
          <li><a href="https://www.ajmc.com/view/quality-of-life-in-alopecia-areata" target="_blank">Quality of Life in Alopecia Areata ‚Äî AJMC</a></li>
        </ul>
      </div>
    </div>
  </section>

  <!-- CAREPEDIA CTA -->
  <div class="carepedia-cta">
    <h3>Want a research-based medical information portal?</h3>
    <p>We build portals for doctors, nonprofits, and medical centers. Tell us about your needs.</p>
    <a href="https://carepedia.org/en/#contact" class="cta-btn">Want a portal? Talk to us</a>
  </div>

  <!-- FOOTER -->
  <footer class="footer">
    <p style="margin-bottom: 16px;">
      Built by <strong>Yuval Kashtkir</strong> and his robot assistants | <a href="https://carepedia.org" style="color:var(--accent-light);text-decoration:none;">Carepedia</a>
    </p>
    <a href="https://carepedia.org/en/#contact" target="_blank" class="portal-request-btn" style="margin-bottom: 20px;">‚ûï Want a portal for another disease?</a>
    <p style="margin-top: 20px; font-size: 15px; opacity: 0.85;">All information on this site is for educational purposes only and does not substitute for professional medical advice.</p>
    <p style="margin-top: 8px; font-size: 13px; opacity: 0.7;"><a href="/disclaimer" style="color:var(--accent-light);text-decoration:underline;">Legal Disclaimer</a> | <a href="https://wa.me/+972526414555" target="_blank" rel="noopener" style="color:var(--accent-light);text-decoration:underline;">Report an Error</a></p>
    <p style="margin-top: 10px; font-size: 14px; opacity: 0.7;">Last updated: February 2026 | Includes quotes from scientific papers</p>
  </footer>

</div>

<!-- SCROLL TO TOP -->
<button class="scroll-top" id="scrollTop" onclick="window.scrollTo({top:0,behavior:'smooth'})"><iconify-icon icon="solar:arrow-up-bold"></iconify-icon></button>

<script>
function toggleMenu() {
  const sidebar = document.getElementById('sidebar');
  const toggle = document.getElementById('menuToggle');
  const overlay = document.getElementById('sidebarOverlay');
  sidebar.classList.toggle('open');
  toggle.classList.toggle('open');
  overlay.classList.toggle('active');
  document.body.style.overflow = sidebar.classList.contains('open') ? 'hidden' : '';
}

function closeMenu() {
  const sidebar = document.getElementById('sidebar');
  const toggle = document.getElementById('menuToggle');
  const overlay = document.getElementById('sidebarOverlay');
  sidebar.classList.remove('open');
  toggle.classList.remove('open');
  overlay.classList.remove('active');
  document.body.style.overflow = '';
}

function navigate(el) {
  document.querySelectorAll('.sidebar nav a').forEach(a => a.classList.remove('active'));
  el.classList.add('active');
  closeMenu();
}

function navigateTo(id) {
  const el = document.getElementById(id);
  if (el) el.scrollIntoView({ behavior: 'smooth' });
  document.querySelectorAll('.sidebar nav a').forEach(a => {
    a.classList.toggle('active', a.getAttribute('href') === '#' + id);
  });
}

function toggleAccordion(header) {
  const body = header.nextElementSibling;
  const isOpen = header.classList.contains('open');
  header.classList.toggle('open');
  body.style.maxHeight = isOpen ? '0' : body.scrollHeight + 'px';
}

function switchTab(tabGroup, tabName) {
  document.querySelectorAll('[data-tab-group="' + tabGroup + '"] .tab-btn').forEach(b => {
    b.classList.toggle('active', b.dataset.tab === tabName);
  });
  document.querySelectorAll('[data-tab-content="' + tabGroup + '"]').forEach(c => {
    c.classList.toggle('active', c.dataset.tab === tabName);
  });
}

// Scroll progress bar
window.addEventListener('scroll', () => {
  const scrollTop = document.getElementById('scrollTop');
  const progressBar = document.getElementById('progressBar');
  const scrolled = window.scrollY;
  const maxScroll = document.documentElement.scrollHeight - window.innerHeight;
  const pct = maxScroll > 0 ? (scrolled / maxScroll) * 100 : 0;
  progressBar.style.width = pct + '%';
  scrollTop.classList.toggle('visible', scrolled > 500);

  // Scroll spy
  const sections = document.querySelectorAll('.section[id], .hero[id]');
  let current = '';
  sections.forEach(s => {
    if (scrolled >= s.offsetTop - 100) current = s.id;
  });
  if (current) {
    document.querySelectorAll('.sidebar nav a').forEach(a => {
      a.classList.toggle('active', a.getAttribute('href') === '#' + current);
    });
  }
});

// Fade-in on scroll (IntersectionObserver)
const fadeEls = document.querySelectorAll('.fade-in');
const observer = new IntersectionObserver((entries) => {
  entries.forEach(entry => {
    if (entry.isIntersecting) {
      entry.target.classList.add('visible');
    }
  });
}, { threshold: 0.1, rootMargin: '0px 0px -50px 0px' });
fadeEls.forEach(el => observer.observe(el));

// Portal search
function searchPortal(query) {
  const resultsDiv = document.getElementById('searchResults');
  if (!query || query.length < 2) {
    resultsDiv.style.display = 'none';
    document.querySelectorAll('.section').forEach(s => s.style.display = '');
    return;
  }
  const q = query.toLowerCase();
  const sections = document.querySelectorAll('.section[id]');
  const matches = [];
  sections.forEach(s => {
    const text = s.textContent.toLowerCase();
    const title = s.querySelector('h2') ? s.querySelector('h2').textContent : '';
    if (text.includes(q)) {
      matches.push({ id: s.id, title: title, el: s });
      s.style.display = '';
    } else {
      s.style.display = 'none';
    }
  });
  if (matches.length > 0 && matches.length < sections.length) {
    resultsDiv.innerHTML = '<div style="background:var(--card);border-radius:var(--radius);padding:16px 20px;box-shadow:var(--shadow);">' +
      '<p style="font-size:14px;color:var(--text-light);margin-bottom:8px;">' + matches.length + ' results found:</p>' +
      matches.map(m => '<a href="#' + m.id + '" onclick="navigateTo(\'' + m.id + '\')" style="display:block;padding:8px 12px;color:var(--primary);text-decoration:none;border-radius:8px;font-weight:600;transition:var(--transition);" onmouseover="this.style.background=\'var(--bg)\'" onmouseout="this.style.background=\'transparent\'">' + m.title + '</a>').join('') +
      '</div>';
    resultsDiv.style.display = 'block';
  } else if (matches.length === sections.length) {
    resultsDiv.style.display = 'none';
  } else {
    resultsDiv.innerHTML = '<div style="background:var(--card);border-radius:var(--radius);padding:16px 20px;box-shadow:var(--shadow);"><p style="font-size:14px;color:var(--text-light);">No results found. Try another word.</p></div>';
    resultsDiv.style.display = 'block';
  }
}
</script>

</body>
</html>
